Related Articles
Prognostic value of KRAS/TP53/PIK3CA in non‑small cell lung cancer
A novel strategy of EGFR‑TKI combined chemotherapy in the treatment of human lung cancer with EGFR‑sensitive mutation
Tumor molecular profiling of NSCLC patients using next generation sequencing
Direct sequencing and amplification refractory mutation system for epidermal growth factor receptor mutations in patients with non-small cell lung cancer
Peripheral lung adenocarcinomas harboring epithelial growth factor receptor mutations with microRNA‑135b overexpression are more likely to invade visceral pleura